Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 51% ± 16% | |
brain | 21 studies | 43% ± 21% | |
peripheral blood | 19 studies | 59% ± 16% | |
intestine | 11 studies | 49% ± 21% | |
kidney | 11 studies | 43% ± 15% | |
eye | 11 studies | 53% ± 15% | |
lymph node | 6 studies | 54% ± 22% | |
liver | 6 studies | 60% ± 19% | |
placenta | 5 studies | 48% ± 25% | |
heart | 5 studies | 45% ± 9% | |
uterus | 5 studies | 62% ± 21% | |
prostate | 5 studies | 47% ± 20% | |
breast | 5 studies | 55% ± 16% | |
bone marrow | 4 studies | 55% ± 23% | |
esophagus | 4 studies | 42% ± 28% | |
skin | 4 studies | 40% ± 13% | |
adipose | 4 studies | 62% ± 24% | |
pancreas | 3 studies | 53% ± 13% | |
adrenal gland | 3 studies | 45% ± 18% | |
stomach | 3 studies | 39% ± 29% | |
thymus | 3 studies | 62% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 17614.76 | 21 / 21 | 100% | 61.47 | 504 / 504 |
breast | 100% | 20344.48 | 459 / 459 | 100% | 75.79 | 1118 / 1118 |
esophagus | 100% | 16032.46 | 1445 / 1445 | 100% | 58.43 | 183 / 183 |
intestine | 100% | 19429.73 | 966 / 966 | 100% | 60.54 | 527 / 527 |
pancreas | 100% | 11111.93 | 328 / 328 | 100% | 55.87 | 178 / 178 |
stomach | 100% | 15321.03 | 359 / 359 | 100% | 57.22 | 286 / 286 |
uterus | 100% | 24661.05 | 170 / 170 | 100% | 69.33 | 459 / 459 |
lung | 100% | 18413.98 | 578 / 578 | 100% | 54.14 | 1154 / 1155 |
thymus | 100% | 25622.40 | 653 / 653 | 100% | 67.96 | 604 / 605 |
prostate | 100% | 21456.16 | 245 / 245 | 100% | 62.58 | 501 / 502 |
ovary | 100% | 26332.94 | 180 / 180 | 100% | 43.02 | 429 / 430 |
brain | 100% | 10638.76 | 2633 / 2642 | 100% | 55.52 | 705 / 705 |
adrenal gland | 100% | 16922.18 | 258 / 258 | 100% | 47.26 | 229 / 230 |
liver | 100% | 11578.49 | 226 / 226 | 99% | 33.67 | 403 / 406 |
kidney | 100% | 15676.87 | 89 / 89 | 99% | 48.96 | 894 / 901 |
skin | 100% | 16969.04 | 1809 / 1809 | 98% | 50.90 | 461 / 472 |
adipose | 100% | 18181.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14840.97 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.91 | 29 / 29 |
spleen | 100% | 26468.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 57.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.36 | 1 / 1 |
muscle | 100% | 10548.59 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 9169.80 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 12024.23 | 900 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 33.55 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008380 | Biological process | RNA splicing |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0006397 | Biological process | mRNA processing |
GO_0006396 | Biological process | RNA processing |
GO_0016607 | Cellular component | nuclear speck |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0034451 | Cellular component | centriolar satellite |
GO_1990446 | Molecular function | U1 snRNP binding |
GO_0050733 | Molecular function | RS domain binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBM39 |
Protein name | RNA binding motif protein 39 RNA-binding protein 39 (CAPER alpha) (CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1) RNA binding motif protein 39 (RNA-binding region (RNP1, RRM) containing 2, isoform CRA_f) |
Synonyms | HCC1 hCG_38221 RNPC2 |
Description | FUNCTION: RNA-binding protein that acts as a pre-mRNA splicing factor . Acts by promoting exon inclusion via regulation of exon cassette splicing . Also acts as a transcriptional coactivator for steroid nuclear receptors ESR1/ER-alpha and ESR2/ER-beta, and JUN/AP-1, independently of the pre-mRNA splicing factor activity (By similarity). . |
Accessions | ENST00000448303.5 Q14498 ENST00000412738.5 G3XAC6 F2Z3E6 A0A087X122 H0Y4X3 ENST00000615771.5 A8MYG5 ENST00000338163.10 ENST00000361162.10 [Q14498-2] ENST00000403542.6 ENST00000528062.7 [Q14498-3] ENST00000476806.5 ENST00000656873.1 H7BZG3 F8WF73 ENST00000434927.5 F2Z2Z5 ENST00000429968.5 ENST00000425184.5 ENST00000449489.5 ENST00000433027.5 ENST00000416529.5 ENST00000490484.7 ENST00000374038.7 ENST00000397370.3 ENST00000444878.5 ENST00000416108.5 F8WF24 H0Y6I9 ENST00000453310.5 ENST00000455343.5 ENST00000426951.5 ENST00000253363.11 [Q14498-1] A0A0U1RQH7 Q5QP23 Q5QP22 A0A0U1RQW2 |